 SUZHOU, China, and ROCKVILLE, MD, Jan. 18, 2023 PRNewswire Ascentage Pharma 6855.HK, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B CHB, and age-related diseases, and Innovent Biologics, Inc. Innovent HKEX: 01801, today announced that the novel drug olverembatinib has been included into the China 2022 National Reimbursement Drug ...... 